Covetrus, Inc. (CVET) |
|
20.99 0 (0%)
|
10-12 16:00 |
|
Open: |
20.93 |
Pre. Close: |
20.99 |
|
High:
|
21 |
Low:
|
20.93 |
|
Volume:
|
5,300,387 |
Market Cap:
|
0(M) |
|
|
|
Technical analysis |
as of: 2022-11-18 4:19:44 PM |
|
Short-term rate:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
|
Mid-term rate:
|
  |
| Target: |
Six months: 24.52 One year: 28.64 |
| Support: |
Support1: 20.95 Support2: 20.93 |
| Resistance: |
Resistance1: 21 Resistance2: 24.52 |
| Pivot: |
20.98 |
| Moving Average: |
MA(5): 20.98 MA(20): 20.98
MA(100): 20.86  MA(250): 19.02 |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 85.7 %D(3): 85.7 |
| RSI: |
RSI(14): 68.7 |
| 52-week: |
High: 21.2 Low: 13.39 |
| Average Vol(K): |
3-Month: 2,988 (K) 10-Days: 5,300 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ CVET ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 14 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
21.02 - 21.12 |
21.12 - 21.21 |
|
Low:
|
20.68 - 20.8 |
20.8 - 20.9 |
|
Close:
|
20.81 - 21 |
21 - 21.16 |
|
Company Description |
|
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private. |
Headline News |
Thu, 13 Oct 2022
Clayton, Dubilier & Rice and TPG Complete Acquisition of Covetrus - Business Wire
Mon, 26 Sep 2022
Covetrus Names Michelle Bonfilio as Chief People Officer - Business Wire
Mon, 13 Jun 2022
Deal Diary: Debevoise, Ropes Aid CD&R, TPG in Covetrus Buyout - The Deal Pipeline
Thu, 02 Jun 2022
Clayton, Dubilier & Rice/TPG Are Not Offering Fair Value To ... - Seeking Alpha
Wed, 25 May 2022
Covetrus to go private in $4 bln deal with CD&R, TPG Capital - Reuters
Wed, 25 May 2022
Covetrus to Be Taken Private for $4 Billion - Barron's
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Distribution |
| Shares Out. |
138 (M) |
| Shares Float |
105 (M) |
|
% Held by Insiders
|
0.6 (%) |
|
% Held by Institutions
|
95.8 (%) |
|
Shares Short
|
4,860 (K) |
|
Shares Short P.Month
|
2,820 (K) |
Stock Financials |
|
EPS
|
-0.22 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
11.3 |
|
Profit Margin (%)
|
-0.9 |
|
Operating Margin (%)
|
-0.3 |
|
Return on Assets (ttm)
|
-0.2 |
|
Return on Equity (ttm)
|
-2.6 |
|
Qtrly Rev. Growth
|
4.1 |
|
Gross Profit (p.s.)
|
6.22 |
|
Sales Per Share
|
33.53 |
|
EBITDA (p.s.)
|
1.14 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
126 (M) |
|
Levered Free Cash Flow
|
131 (M) |
Stock Valuations |
|
PE Ratio
|
-95.41 |
|
PEG Ratio
|
1.6 |
|
Price to Book value
|
1.85 |
|
Price to Sales
|
0.62 |
|
Price to Cash Flow
|
22.95 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
